Dr. Samba Reddy, a distinguished Regents Professor at Texas A&M University School of Medicine, has been named the Editor of Experimental Neurology, a leading international medical journal. Known for its high-impact research on neurological disorders, the journal boasts an impressive impact factor of 5.6.

Dr. Reddy, who directs the Institute of Pharmacology and Neurotherapeutics, brings over two decades of experience in academia and neurotherapeutics research. His groundbreaking work, particularly in developing treatments for epilepsy and other brain disorders, has garnered global recognition. His research has led to FDA-approved medications like Brexanolone and Ganaxolone.

As a TAMUS Chancellor EDGES Fellow and Board-Certified Pharmacist, Dr. Reddy’s research is heavily funded by the NIH and DOD, with annual grants exceeding $1.6 million. His dedication extends to education, mentoring numerous students and serving on various national panels.

Dr. Reddy’s appointment highlights his commitment to advancing neuroscience and improving healthcare outcomes. Originally from Cherlapally, Telangana, Dr. Reddy’s leadership promises to uphold and enhance the journal’s tradition of excellence.